Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Evaluation of the DAPT score in patients who undergo percutaneous coronary intervention in England and Wales (CROSBI ID 278818)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Kwok, Chun Shing ; Kinnaird, Tim ; Ludman, Peter ; Mohamed, Mohamed ; Borovac, Josip Anđelo ; Sirker, Alex ; Mamas, Mamas A. Evaluation of the DAPT score in patients who undergo percutaneous coronary intervention in England and Wales // Cardiovascular revascularization medicine, 21 (2020), 12; 1509-1514. doi: 10.1016/j.carrev.2020.05.003

Podaci o odgovornosti

Kwok, Chun Shing ; Kinnaird, Tim ; Ludman, Peter ; Mohamed, Mohamed ; Borovac, Josip Anđelo ; Sirker, Alex ; Mamas, Mamas A.

engleski

Evaluation of the DAPT score in patients who undergo percutaneous coronary intervention in England and Wales

This study aims to evaluate the temporal changes in DAPT score and determine whether there is an association between DAPT score and mortality. We analyzed all patients who underwent PCI in England and Wales 2007–2014. Statistical analyses were performed evaluating the DAPT score according to ≥2 and <2 cutoffs. Trends in DAPT score and logistic regressions were used to determine the association between DAPT score and 30 day, 1 year and 3 year mortality. A total of 243, 440 patients were included in the analysis and the proportion of patients with DAPT score ≥ 2 was 35.6% (n = 86, 550). The trend in DAPT score ≥ 2 showed an overall decline over time from 38.5% in 2007 to 34.5% in 2014. In more recent years, patients were older and a greater proportion were diabetic and had myocardial infarction on presentation and there was a significant decline in patients receiving paclitaxel stent (23.7% in 2007 to 0.2% in 2014). Patients with DAPT score ≥ 2 were more likely to be male, have previous CABG and have glycoprotein IIB/IIIa inhibitors. At 3 year follow up there was a significant difference in death compared DAPT ≥ 2 vs <2 (5.2% vs 5.5%, p < 0.001). DAPT score ≥ 2 was associated with reduced mortality at 1 year (OR 0.87 95%CI 0.82–0.92, p < 0.001) and 3 years (OR 0.82 95%CI 0.79–0.86, p < 0.001) after adjustments. These findings suggest that the DAPT score classifies 1 in 3 patients as having scores ≥2 and these patients have reduced odds of long-term mortality.

percutaneous coronary intervention ; mortality ; DAPT score

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

21 (12)

2020.

1509-1514

objavljeno

1553-8389

10.1016/j.carrev.2020.05.003

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost